Manulife (Manufacturers Life Insurance)
CTXR icon

Manulife (Manufacturers Life Insurance)’s Citius Pharmaceuticals CTXR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,982
Closed -$88.7K – 3041
2022
Q1 		$88.7K Sell
1,982
-224
-10% -$8.85K ﹤0.01% 2973
2021
Q4 		$85 Buy
2,206
+1,758
+392% +$79.7K ﹤0.01% 3069
2021
Q3 		$23K Sell
448
-2,194
-83% -$110K ﹤0.01% 3127
2021
Q2 		$230K Buy
+2,642
New +$159K ﹤0.01% 3008

Other funds holding CTXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CTXR Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Citius Pharmaceuticals (CTXR) in Q2 2022, closing a stake of 1,982 shares — an estimated $88.7K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CTXR in Q2 2021 and held it in 4 quarters. The position peaked at $230K in Q2 2021. 60 funds tracked by Wall St. Rank hold CTXR as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Citius Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,982 Citius Pharmaceuticals shares in Q2 2022, an estimated $88.7K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Citius Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • Manulife (Manufacturers Life Insurance)'s Citius Pharmaceuticals position peaked at $230K in Q2 2021.
  • 60 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.